Capturing Dynamic Phage–Pathogen Coevolution by Clinical Surveillance

Why It Matters

Understanding phage‑bacteria coevolution informs cholera outbreak dynamics and guides phage‑based interventions, highlighting the need for ongoing genomic surveillance.

Key Takeaways

• PLE11 spread to >90% of V. cholerae within 9 months
• PLE11 blocks ICP1 infection despite Odn, CRISPR, Adi mechanisms
• Rta protein disables ICP1 by preventing tail assembly
• ICP1 evolved CRISPR‑Cas and TMP mutations to bypass PLE11
• Surveillance captured real‑time phage‑bacteria arms race

Pulse Analysis

The discovery of PLE11 underscores how mobile genetic elements can swiftly reshape pathogen fitness in endemic settings. By integrating whole‑genome sequencing of both Vibrio cholerae and its predatory phage ICP1, researchers revealed that a single satellite element can dominate a bacterial population, effectively neutralising the most common anti‑phage strategies. This finding expands the known repertoire of bacterial defence systems beyond CRISPR and highlights the evolutionary pressure exerted by lytic phages on pandemic cholera lineages.

Rta, the 80‑amino‑acid protein encoded by PLE11, represents a novel class of anti‑phage factors that target the phage tail’s tape‑measure protein, halting virion assembly and producing tailless capsids. Laboratory evolution experiments pinpointed specific mutations in ICP1’s tape‑measure protein that restore infectivity, mirroring the adaptations later observed in clinical isolates. This parallel between experimental and natural evolution provides a predictive framework for anticipating phage escape routes, which is critical for designing robust phage‑therapy cocktails or engineering synthetic defence elements.

The broader implication for public health is the demonstration that real‑time genomic surveillance can capture the dynamics of pathogen‑phage interactions during an outbreak. By tracking the rise of PLE11 and the subsequent emergence of CRISPR‑Cas‑armed ICP1 variants, health authorities gain actionable insights into the likely trajectory of cholera epidemics. Such data can inform vaccine strain selection, guide the deployment of phage‑based biocontrol measures, and reinforce the importance of integrating microbial ecology into infectious disease monitoring programs.